SCHEMBL13470

SCHEMBL13470

Cc1cc(Br)ccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30337581 1.00 — —
SCHEMBL5347385 0.97 ACHE (0.40) —
SCHEMBL47042 0.79 — —
Hydrochloric Acid SCHEMBL27656812 0.77 HDAC1 (0.44) —
Fluoride SCHEMBL27726514 0.77 HDAC1 (0.44) —
SCHEMBL17784486 0.77 HDAC1 (0.44) —
SCHEMBL8146926 0.75 CYP2A6 (0.46) —
SCHEMBL26750806 0.75 CYP2A6 (0.46) —
SCHEMBL40336 0.75 — —
SCHEMBL29388695 0.75 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 733 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110078633-B Preparation method of 4-fluoro-3-methoxy-5-methylaniline hydrochloride 爱斯特(成都)生物制药股份有限公司 2021-05-11 — — CN claimed
WO-2020237806-A1 PREPARATION METHOD FOR 4-FLUORINE-3-METHOXYL-5-METHYLANILINE HYDROCHLORIDE 爱斯特(成都)生物制药股份有限公司 2020-12-03 — — WO claimed
EP-0068038-A1 (+)-(4R,6S)-(E)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same MERCK & CO. INC. (US) 1983-01-05 — — EP claimed
US-20260078117-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS INC (US) 2026-03-19 — — US disclosed
EP-3897833-B1 INHIBITORS OF APOL1 AND METHODS OF USING SAME VERTEX PHARMA (US) 2026-02-04 — — EP disclosed
US-12459958-B2 Tricyclic compounds as HPK1 inhibitor and the use thereof BEONE MEDICINES I GMBH (CH) 2025-11-04 — — US disclosed
US-20250326770-A1 BENZOTRIAZOLE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-10-23 — — US disclosed
US-20250296939-A1 BENZOTHIOPHENE COMPOUND KYOTO PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2025-09-25 — — US disclosed
US-20250282724-A1 BENZOTRIAZOLE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-09-11 — — US disclosed
US-12378260-B2 Benzotriazole compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2025-08-05 — — US disclosed
WO-2025119206-A1 GLP-1 RECEPTOR TARGETING COMPOUNDS AND USES THEREOF FORTVITA BIOLOGICS INC. (KY) 2025-06-12 — — WO disclosed
US-4855321-A Antihypercholesterolemic compounds MERCK & CO., INC. (US) 1989-08-08 — — US disclosed
WO-1989005639-A1 NOVEL HMG-CoA REDUCTASE INHIBITORS RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-06-29 — — WO disclosed
CN-1030761-A Phosphorated 3-hydroxyl-3-first glutaryl CoA-reductase inhibitors, new intermediate and method SQUIBB & SONS INC (US) 1989-02-01 — — CN disclosed
CN-88103091-A Phosphorous HMG-COA reductase inhibitor, new intermediate and using method SQUIBB & SONS INC (US) 1988-12-21 — — CN disclosed
US-4772626-A ENZYME INHIBITORS, ANTILIPEMIC AGENTS, TETRAHYDRO-HYDROXYPYRANONES MERCK & CO., INC. (US) 1988-09-20 — — US disclosed
EP-0232997-A1 Antihypercholesterolemic compounds MERCK & CO. INC. (US) 1987-08-19 — — EP disclosed
US-4620025-A NICKEL COMPLEX CATALYSTS MERCK & CO., INC. (US) 1986-10-28 — — US disclosed
EP-0068038-B1 (+)-(4R,6S)-(E)-6-(2-(4'-FLUORO-3,3',5-TRIMETHYL-(1,1'-BIPHENYL)-2-YL)ETHENYL)-3,4,5,6-TETRAHYDRO-4-HYDROXY-2H-PYRAN-2-ONE, A PROCESS FOR PREPARING AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME MERCK & CO. INC. (US) 1985-09-25 — — EP disclosed
US-3947460-A SEDATIVES-HYPNOTIC, TRANQUILIZER SANDOZ, INC. (US) 1976-03-30 — — US disclosed
Send feedback